Oval Medical Technologies is dedicated to bringing the best patient centric, single use, autoinjector platforms to the global market.
Oval’s approach to device development combines a deep understanding of patient need with advance autoinjection technology, allowing customization of platforms and the creation of devices that work for any patient or formulation.
Oval platforms address:
- Fragile formulations
- Viscous formulations
- Non-Newtonian characteristics
- Delivery volumes up to 3ml
- Subcutaneous injection
- Intramuscular injection
Combination device opportunities include:
- Epinephrine autoinjector for anaphylactic shock that is ultra-portable and easy to use
- Sumatriptan autoinjector for cluster headaches and migraine attacks to make patient lives simpler